Forero-Torres, A., Ramchandren, R., Yacoub, A., Wertheim, M. S., Edenfield, W. J., Caimi, P., . . . Phillips, T. J. (2019). Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies. Blood.
Citação norma ChicagoForero-Torres, Andres, et al. "Parsaclisib, a Potent and Highly Selective PI3Kδ Inhibitor, in Patients With Relapsed or Refractory B-cell Malignancies." Blood 2019.
Citação norma MLAForero-Torres, Andres, et al. "Parsaclisib, a Potent and Highly Selective PI3Kδ Inhibitor, in Patients With Relapsed or Refractory B-cell Malignancies." Blood 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.